Natural products derived from traditional chinese medicine as novel inhibitors of the epidermal growth factor receptor.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Combinatorial chemistry & high throughput screening

• Publication date

  2010-11-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/138620710793360266PMID 20883187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

  2010cited by this paper
• Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.

  2010cited by this paper
• Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

  2010cited by this paper
• Inhibition of epidermal growth factor receptor over-expressing cancer cells by the aphorphine-type isoquinoline alkaloid, dicentrine.

  2010cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

  2009cited by this paper
• The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate's activity in cancer cells.

  2009cited by this paper
• Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells

  2009cited by this paper
• Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.

  2008cited by this paper
• Anti-cancer natural product library from traditional chinese medicine.

  2008cited by this paper
• From traditional Chinese medicine to rational cancer therapy.

  2007cited by this paper
• Diagnosis and therapy of oral squamous cell carcinoma

  2007cited by this paper
• Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma

  2007cited by this paper
• Willmar Schwabe Award 2006: Antiplasmodial and Antitumor Activity of Artemisinin - From Bench to Bedside

  2007cited by this paper
• Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells

  2007cited by this paper
• Oral cancer.

  2007cited by this paper
• Natural products as sources of new drugs over the last 25 years.

  2007cited by this paper
• Molecular biology of oral cavity squamous cell carcinoma.

  2006cited by this paper
• Epidemiology of head and neck cancer: Magnitude of the problem

  2005cited by this paper
• Pharmacogenetics for individualized cancer chemotherapy.

  2005cited by this paper
• Erlotinib in previously treated non-small-cell lung cancer.

  2005cited by this paper
• Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines.

  2004cited by this paper
• Epidermal Growth Factor Receptor-deficient Mice Have Delayed Primary Endochondral Ossification Because of Defective Osteoclast Recruitment*

  2004cited by this paper
• Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.

  2004cited by this paper
• Molecular modes of action of artesunate in tumor cell lines.

  2003cited by this paper
• Recent development of antitumor agents from Chinese herbal medicines. Part II. High molecular compounds(3).

  2003cited by this paper
• Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells.

  2003cited by this paper
• Recent development of antitumor agents from chinese herbal medicines; part I. Low molecular compounds.

  2003cited by this paper
• Protein expression profiles indicative for drug resistance of non-small cell lung cancer

  2002cited by this paper
• Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients.

  2002cited by this paper
• β‐Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases

  2002cited by this paper
• Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.

  2002cited by this paper
• Signal transduction pathways: the molecular basis for targeted therapies.

  2002cited by this paper
• Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines

  2002cited by this paper
• Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Malignant glioma: genetics and biology of a grave matter.

  2001cited by this paper
• Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.

  1998cited by this paper
• Anti-tumor effects of d-dicentrine from the root of Lindera megaphylla.

  1998cited by this paper
• Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.

  1997cited by this paper
• Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.

  1994cited by this paper
• Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms.

  1993cited by this paper
• Expression of resistance factors (P‐glycoprotein, glutathione S‐transferase‐π, and topoisomerase II) and their interrelationship to proto‐oncogene products in renal cell carcinomas

  1993cited by this paper
• Immunocytochemical detection of oncoproteins in animal and human tumor lines with acquired or inherent multidrug resistance.

  1992cited by this paper
• Antibody-directed therapy of multidrug-resistant tumor cells

  1992cited by this paper
• Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.

  1992cited by this paper
• Traditional Chinese medicine and the search for new antineoplastic drugs.

  1988cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Qinghaosu (artemisinin): an antimalarial drug from China.

  1985cited by this paper

• Identification of potential edible spices as EGFR and EGFR mutant T790M/L858R inhibitors by structure-based virtual screening and molecular dynamics

  2023cites this paper
• In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors

  2022cites this paper
• Inhibitory effects of salidroside on MCF-7 breast cancer cells in vivo

  2020cites this paper
• Medicinal Plants and DNA Methylation of Cancer

  2015cites this paper
• Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib

  2015cites this paper
• Anti-epidermal growth factor receptor tyrosine kinase activities of traditional Chinese medicine for cancer treatment

  2014cites this paper
• In silico molecular docking study of natural compounds on wild and mutated epidermal growth factor receptor

  2014cites this paper
• Antiangiogenic Activity and Pharmacogenomics of Medicinal Plants from Traditional Korean Medicine

  2013cites this paper
• Lanthanide-doped inorganic nanocrystals as luminescent biolabels.

  2012cites this paper
• Toxicities by herbal medicines with emphasis to traditional Chinese medicine.

  2011cites this paper